Abstract Details

Title Symbiosis of Neuro-Interventionists: From Parallel Practice to Interdisciplinary Patient Care

Topic Neurologic ��ɫ��

Presentation(s) P05 - (-)

Poster/Presentation
Number 002

Objective

Background BACKGROUND: The niche of neuro-intervention becomes intricate when neurologists further specialize in neuro-endovascular procedures. In centers with established endovascular treatment by radiologists, neurosurgeon, cardiologists or vascular surgeons, budding interventional neurologists may strive to partner these disciplines at service provision. The role of interventional neurologists and the optimal framework of collaboration among various specialties remain unclear.

Design/Methods DESIGN/METHODS: Institutional Review Board approved the study. We evaluated this collaborative model by a quantitative framework construct survey on 4 major aspects: philosophy (believes in benefits of interprofessional collaboration, knowledge of each other's treatment approach), trust, process (knowledge exchange, physician centrality, conflicts) and outcomes (job satisfaction, personal growth, intention to leave, research output). Doctors, nurses and radiographers were invited by mail to complete the survey. One-way ANOVA test or Kruskal-Wallis test were used for statistical analyses.

Results RESULTS: Thirty-eight team-members (38 / 53, 71.7%) completed the questionnaire. Within the continuum from parallel practice to integrative model, 24 responders (63.2%) defined the current mode of collaboration as multidisciplinary, integrative or interdisciplinary. Majority of doctors (66.7%) and radiographers (62.5%) expressed a strong believe in benefits of interprofessional collaboration but only 28.6% nurses agreed. Doctors showed a stronger believe that the collaboration enable a better clinical outcome after endovascular intervention (p= 0.013). While most doctors enjoyed a high degree of autonomy and more opportunities for personal growth and research through the collaboration, most nurses and radiographers had less autonomy and described the collaboration as physician oriented (all p<0.05).

Conclusions CONCLUSIONS: A collaborative paradigm for neuro-interventional service may improve the clinical outcome of patients. However, the protocol-driven model may diminish autonomy and job satisfaction of nurses and radiographers.

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Lawrence K. Wong	No disclosure on file
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Ted M. Burns, MD	Dr. Burns has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��